Sjögren’s Syndrome: Interface of Immunology and Neurology
Sjögren’s syndrome (SS) is characterized by dry eyes and dry mouth, due to focal lymphocytic infiltrates of the lacrimal and salivary glands. SS patients also have a spectrum of extraglandular manifestations including skin, joint, pulmonary, renal, cardiovascular, hematopoietic, neurological, and lymphoid proliferation. Indeed, the neurological manifestations are among the most challenging perplexities for the clinical rheumatologists and other specialists involved in their care. In addition, SS patients have a high incidence of fatigue, self-described cognitive impairment, and myalgias that baffle the rheumatologist because they do not correlate closely with either glandular or extraglandular manifestations. An understanding of the neuropathies in SS seems a good starting point in approaching the unmet needs of the SS patient. In particular, it is necessary to move beyond the narrowly defined “innate” and “adaptive” immune response (i.e., T-cell-directed B-cell production of autoantibodies) to the more general “danger hypothesis” that includes interactions of the immune system with the brain (hypothalamic and adrenal axis), midbrain amplification of neurokines and pain pathways, and prostaglandin pathways that play a role in vascular tone and blood pressure regulation.
KeywordsSjögren’s syndrome Neuropathies Central nervous system Danger hypothesis Dry eyes Dry mouth Sicca symptoms Brain fog
Dr. Robert I. Fox and Dr. Julius Birnbaum would like to acknowledge Dr. Carla Martin Fox for her contribution toward this chapter.
- 20.Segal BM, Pogatchnik B, Holker E, Liu H, Sloan J, Rhodus N, et al. Primary Sjogren’s syndrome: cognitive symptoms, mood, and cognitive performance. Acta Neurol Scand [Research Support, NIH, Extramural Research Support, Non-US Gov’t]. 2012;125(4):272–8.Google Scholar
- 21.Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology [Consensus Development Conference Practice Guideline Research Support, Non-US Gov’t]. 2015;85(2):177–89.Google Scholar
- 24.Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol [Research Support, Non-US Gov’t Review]. 2016;15(3):292–303.Google Scholar